Immune-Related Adverse Events and Efficacy-The More It Hurts, the Better It Works?-Reply
JAMA Oncol
.
2021 Jun 1;7(6):945.
doi: 10.1001/jamaoncol.2021.0732.
Authors
Jarushka Naidoo
1
2
3
,
Jiajia Zhang
1
4
5
,
Bairavi Shankar
1
Affiliations
1
Johns Hopkins University School of Medicine, Baltimore, Maryland.
2
Beaumont Hospital, Dublin, Ireland.
3
Royal College of Surgeons of Ireland, Dublin, Ireland.
4
Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland.
5
The Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University, Baltimore, Maryland.
PMID:
33914013
DOI:
10.1001/jamaoncol.2021.0732
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immune System Diseases*